BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12(8): 1175-1181 [PMID: 16534867 DOI: 10.3748/wjg.v12.i8.1175]
URL: https://www.wjgnet.com/1007-9327/full/v12/i8/1175.htm
Number Citing Articles
1
Yun Hee Kang, Mi-Young Park, Do-Young Yoon, Seung Ro Han, Chung Il Lee, Na Young Ji, Pyung-Keun Myung, Hee Gu Lee, Jae Wha Kim, Young Il Yeom, Ye Jin Jang, Dong Kuk Ahn, Jong Wan Kim, Eun Young Song. Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2Cancer Letters 2012; 318(2): 226 doi: 10.1016/j.canlet.2011.12.023
2
Fabio Grizzi, Barbara Franceschini, Barbara Fiamengo, Carlo Russo, Nicola Dioguardi. Vascular architecture: is it a helpful histopathological biomarker for hepatocellular carcinoma?Journal of Zhejiang University SCIENCE B 2007; 8(4): 217 doi: 10.1631/jzus.2007.B0217
3
Mekky Mohammed Abouzied, Heba M. Eltahir, Michael Atef Fawzy, Nabil Mohie Abdel-Hamid, Amany Saber Gerges, Hesham Mohmoud El-Ibiari, Maiiada Hassan Nazmy. Estimation of Leucine Aminopeptidase and 5-Nucleotidase Increases Alpha-Fetoprotein Sensitivity in Human Hepatocellular Carcinoma CasesAsian Pacific Journal of Cancer Prevention 2015; 16(3): 959 doi: 10.7314/APJCP.2015.16.3.959
4
Ya-Wen Teng, Mihai G. Mehedint, Timothy A. Garrow, Steven H. Zeisel. Deletion of Betaine-Homocysteine S-Methyltransferase in Mice Perturbs Choline and 1-Carbon Metabolism, Resulting in Fatty Liver and Hepatocellular CarcinomasJournal of Biological Chemistry 2011; 286(42): 36258 doi: 10.1074/jbc.M111.265348
5
Manar Mahmoud El-Tonsy, Hesham Mohammed Hussein, Thanaa El-Sayed Helal, Rania Ayman Tawfik, Khalid Mohamed Koriem, Hend Mohamed Hussein. Schistosoma mansoni infection: Is it a risk factor for development of hepatocellular carcinoma?Acta Tropica 2013; 128(3): 542 doi: 10.1016/j.actatropica.2013.07.024
6
Roli Saxena, Yogesh Kumar Chawla, Indu Verma, Jyotdeep Kaur. Effect of IL-12B, IL-2, TGF-β1, and IL-4 Polymorphism and Expression on Hepatitis B ProgressionJournal of Interferon & Cytokine Research 2014; 34(2): 117 doi: 10.1089/jir.2013.0043
7
Yasunori Matsuda, Yoko Yamagiwa, Koji Fukushima, Yoshiyuki Ueno, Tooru Shimosegawa. Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinomaHepatology Research 2008; 38(11): 1098 doi: 10.1111/j.1872-034X.2008.00387.x
8
Takashi Sugihara, Satoshi Tanaka, Ignacia Braga-Tanaka, Hayato Murano, Masako Nakamura-Murano, Jun-ichiro Komura. Screening of biomarkers for liver adenoma in low-dose-rate γ-ray-irradiated miceInternational Journal of Radiation Biology 2018; 94(4): 315 doi: 10.1080/09553002.2018.1439193
9
Ying Liu, Ke Li, Zhonghai Ren, Shenglei Li, Hongyan Zhang, Qingxia Fan. Clinical Implication of Elevated Human Cervical Cancer Oncogene-1 Expression in Esophageal Squamous Cell CarcinomaJournal of Histochemistry & Cytochemistry 2012; 60(7): 512 doi: 10.1369/0022155412444437
10
Lien-Chin Chen, Mei-Ying Liu, Yung-Chin Hsiao, Wai-Kok Choong, Hsin-Yi Wu, Wen-Lian Hsu, Pao-Chi Liao, Ting-Yi Sung, Shih-Feng Tsai, Jau-Song Yu, Yu-Ju Chen. Decoding the Disease-Associated Proteins Encoded in the Human Chromosome 4Journal of Proteome Research 2013; 12(1): 33 doi: 10.1021/pr300829r
11
Sachiko Ogasawara, Masamichi Nakayama, Jun Akiba, Hironori Kusano, Hirohisa Yano. Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell lineOncology Letters 2017; 14(2): 2170 doi: 10.3892/ol.2017.6451
12
Münevver Demir, Friederike Grünewald, Sonja Lang, Christoph Schramm, Andrea Bowe, Vera Mück, Fabian Kütting, Tobias Goeser, Hans-Michael Steffen. Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patientsMedicine 2016; 95(38): e4602 doi: 10.1097/MD.0000000000004602
13
Yu Li, Jing Xu, Li Chen, Wei-De Zhong, Zheng Zhang, Li Mi, Yang Zhang, Cheng-Gong Liao, Hui-Jie Bian, Jian-Li Jiang, Xiang-Min Yang, Xiao-Yan Li, Chun-Mei Fan, Ping Zhu, Li Fu, Zhi-Nan Chen. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detectionHistopathology 2009; 54(6): 677 doi: 10.1111/j.1365-2559.2009.03280.x
14
Hala M. Abdul-Al, Hala R. Makhlouf, Guanghua Wang, Zachary D. Goodman. Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinomaHuman Pathology 2008; 39(2): 209 doi: 10.1016/j.humpath.2007.06.004
15
Yongmei Wu, Wenju Xu, Yan Wang, Yali Yuan, Ruo Yuan. Silver–graphene oxide nanocomposites as redox probes for electrochemical determination of α-1-fetoproteinElectrochimica Acta 2013; 88: 135 doi: 10.1016/j.electacta.2012.10.081
16
Dalia Omran, Serag Esmat, Heba Sedrac, Ahmad ElBadry, Dina Ismail, Laila Rashed. Can we use GP73 as a biomarker for the detection of hepatocellular carcinoma?Egyptian Liver Journal 2011; 1(1): 43 doi: 10.1097/01.ELX.0000397027.33294.16
17
M. A. Abdelwa, M. M. Elbedew, A. M. Amin, A. K. Tawfik. Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis PatientsResearch Journal of Immunology 2016; 10(1): 1 doi: 10.3923/rji.2017.1.7
18
Muhammad Usman Ghani, Asma Haque, Muhammad Sarfaraz Iqbal, Usman Ali Ashfaq, Muhammad Shareef Mausood, Muhammad Qasim, Shah Jahan, Farwa Batool Shamsi, Muhammad Yousaf. TGF-β1 rs1800469 gene polymorphism in the development of cirrhosis & hepatocellular carcinoma in Pakistani HCV patientsFuture Virology 2019; 14(10): 663 doi: 10.2217/fvl-2019-0047
19
Sahar A. Helmy, Mohamed El-Mesery, Amro El-Karef, Laila A. Eissa, Amal M. El Gayar. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo modelLife Sciences 2019; 233: 116673 doi: 10.1016/j.lfs.2019.116673
20
Xishan Li, Jianpeng Wang, Wang Li, Zilin Huang, Weijun Fan, Yumin Chen, Lijie Shen, Tao Pan, Peihong Wu, Ming Zhao. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastasesInternational Journal of Hyperthermia 2012; 28(8): 721 doi: 10.3109/02656736.2012.736669
21
Gang Hu, Jaakko Tuomilehto, Eero Pukkala, Timo Hakulinen, Riitta Antikainen, Erkki Vartiainen, Pekka Jousilahti. Joint effects of coffee consumption and serum gamma‐glutamyltransferase on the risk of liver cancerHepatology 2008; 48(1): 129 doi: 10.1002/hep.22320
22
Dincer Ozgor, Emrah Otan. HCC and Tumor Biomarkers: Does One Size Fits All?Journal of Gastrointestinal Cancer 2020; 51(4): 1122 doi: 10.1007/s12029-020-00485-x
23
Meng Zhang, Lin Wang, Haiping Zhang, Juan Cong, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part AProgress in Molecular Biology and Translational Science 2019; 162: 349 doi: 10.1016/bs.pmbts.2018.12.008
24
Sukki Cho, Kyung-Min Ryu, Yoon-Jin Hwang, Eung Bae Lee. Prognostic Factors for Pulmonary Metastasectomy in the Treatment of Hepatocellular CarcinomaJournal of Thoracic Oncology 2010; 5(8): 1251 doi: 10.1097/JTO.0b013e3181e2fc9b
25
Zahra Heidari, Bita Moudi. Application of Tumor Biomarkers as Screening Tools in Early Detection of Hepatocellular CarcinomaGene, Cell and Tissue 2015; 2(4) doi: 10.17795/gct-33012
26
ZHENHAI ZHANG, CHENGKUN QIN, YAGUANG WU, ZHONGXUE SU, GUOZHE XIAN, BO HU. CCR9 as a prognostic marker and therapeutic target in hepatocellular carcinomaOncology Reports 2014; 31(4): 1629 doi: 10.3892/or.2014.2998
27
Otis W. Brawley. Holland-Frei Cancer Medicine2017; : 1 doi: 10.1002/9781119000822.hfcm039
28
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNAMolecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
29
Kewal K. Jain. Applications of Biotechnology in Oncology2014; : 87 doi: 10.1007/978-1-4614-9245-0_5
30
Zhizhou Kuang, Ruochun Huang, Zhimin Yang, Zhiqiang Lv, Xinyan Chen, Fuping Xu, Yu-Hua Yi, Jian Wu, Ruo-Pan Huang. Quantitative screening of serum protein biomarkers by reverse phase protein arraysOncotarget 2018; 9(66): 32624 doi: 10.18632/oncotarget.25976
31
Lamiaa N. Hammad, Sahar M. Abdelraouf, Fetouh S. Hassanein, Walid A. Mohamed, Mona F. Schaalan. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: Potential biomarkers for a more favorable prognosis?Journal of Immunotoxicology 2013; 10(4): 380 doi: 10.3109/1547691X.2012.758198
32
Setor K. Kunutsor, Tanefa A. Apekey, Mieke Van Hemelrijck, Giliola Calori, Gianluca Perseghin. Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: Systematic review and meta-analysisInternational Journal of Cancer 2015; 136(5): 1162 doi: 10.1002/ijc.29084
33
Laetitia Fartoux, Thomas Decaens. Contribution of biomarkers and imaging in the management of hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2011; 35: S21 doi: 10.1016/S2210-7401(11)70004-3
34
Roli Saxena, Yogesh Kumar Chawla, Indu Verma, Jyotdeep Kaur. IL-6(−572/−597) polymorphism and expression in HBV disease chronicity in an Indian populationAmerican Journal of Human Biology 2014; 26(4): 549 doi: 10.1002/ajhb.22562
35
Manar Obada, Marwa Helal, Tarek Abd El Hakeem, Hassan Abd El Hady, Ahmed Raouf. The value of serum neopterin as a potential marker of hepatocellular carcinomaEgyptian Liver Journal 2013; 3(3): 97 doi: 10.1097/01.ELX.0000429700.41933.20
36
Shreetama Bandyopadhayaya, Chandi C. Mandal. Precision Medicine in Oncology2020; : 61 doi: 10.1002/9781119432487.ch2
37
Manjula Kiran, Yogesh K. Chawla, Meenu Jain, Jyotdeep Kaur. Haplotypes of Microsomal Epoxide Hydrolase and X-Ray Cross-Complementing Group 1 Genes in Indian Hepatocellular Carcinoma PatientsDNA and Cell Biology 2009; 28(11): 573 doi: 10.1089/dna.2009.0921
38
Thanaa El.A. Helal, Nehal A. Radwan, Zeinab Abdel Kader, Noha A.H. Helmy, Shimaa Y.A. Hammad. Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesionsAnnals of Diagnostic Pathology 2012; 16(5): 330 doi: 10.1016/j.anndiagpath.2012.01.003
39
Xiaoyue Zhang, Xiang Ren, Wei Cao, Yueyun Li, Bin Du, Qin Wei. Simultaneous electrochemical immunosensor based on water-soluble polythiophene derivative and functionalized magnetic materialAnalytica Chimica Acta 2014; 845: 85 doi: 10.1016/j.aca.2014.05.025
40
Young Sun Kim, Kyung Nam Kang, Yong Sung Shin, Ji Eun Lee, Ji Young Jang, Chul Woo Kim. Diagnostic value of combining tumor and inflammatory biomarkers in detecting common cancers in KoreaClinica Chimica Acta 2021; 516: 169 doi: 10.1016/j.cca.2021.02.002
41
Michael D. Lucroy. Clinical Biochemistry of Domestic Animals2008; : 751 doi: 10.1016/B978-0-12-370491-7.00025-8
42
Alicja Chrzanowska, Wojciech Graboń, Magdalena Mielczarek-Puta, Anna Barańczyk-Kuźma. Significance of arginase determination in body fluids of patients with hepatocellular carcinoma and liver cirrhosis before and after surgical treatmentClinical Biochemistry 2014; 47(12): 1056 doi: 10.1016/j.clinbiochem.2014.03.019
43
Kwang Hoe Kim, Jin Young Kim, Jong Shin Yoo. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinomaExpert Review of Proteomics 2019; 16(7): 553 doi: 10.1080/14789450.2019.1626235
44
Iman A. Abd El Gawad, Ghada I. Mossallam, Noha H. Radwan, Heba M. Elzawahry, Niveen M. Elhifnawy. Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patientsJournal of the Egyptian National Cancer Institute 2014; 26(2): 79 doi: 10.1016/j.jnci.2014.01.001
45
Jin Un Kim, Mohamed I F Shariff, Mary M E Crossey, Maria Gomez-Romero, Elaine Holmes, I Jane Cox, Haddy K S Fye, Ramou Njie, Simon D Taylor-Robinson. Hepatocellular carcinoma: Review of disease and tumor biomarkersWorld Journal of Hepatology 2016; 8(10): 471-484 doi: 10.4254/wjh.v8.i10.471
46
Patricia Aguilar-Melero, María-José Prieto-Álamo, Juan Jurado, Arne Holmgren, Carmen Pueyo. Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1Journal of Proteomics 2013; 79: 161 doi: 10.1016/j.jprot.2012.12.005
47
Zhicheng Yao, Changchang Jia, Yan Tai, Hao Liang, Zhaozhong Zhong, Zhiyong Xiong, Meihai Deng, Qi Zhang. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinomaAging 2020; 12(12): 11843 doi: 10.18632/aging.103355
48
Quynh Hoa Tran, Van Gio Nguyen, Cong Manh Tran, Minh Nam Nguyen. Down-regulation of solute carrier family 10 member 1 is associated with early recurrence and poorer prognosis of hepatocellular carcinomaHeliyon 2021; 7(3): e06463 doi: 10.1016/j.heliyon.2021.e06463
49
Issei Saeki, Takahiro Yamasaki, Masaki Maeda, Takuro Hisanaga, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida. Evaluation of the “assessment for continuous treatment with hepatic arterial infusion chemotherapy” scoring system in patients with advanced hepatocellular carcinomaHepatology Research 2018; 48(3): E87 doi: 10.1111/hepr.12932
50
William E. Owen, Richard F. Roberts, William L. Roberts. Performance characteristics of the LiBASys® des-gamma-carboxy prothrombin assayClinica Chimica Acta 2008; 389(1-2): 183 doi: 10.1016/j.cca.2007.11.031
51
Keun Na, Eun-Young Lee, Hyoung-Joo Lee, Kwang-Youl Kim, Hanna Lee, Seul-Ki Jeong, An-Sung Jeong, Sang Yun Cho, Sun A. Kim, Si Young Song, Kyung Sik Kim, Sung Won Cho, Hoguen Kim, Young-Ki Paik. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinomaPROTEOMICS 2009; 9(16): 3989 doi: 10.1002/pmic.200900105
52
Raghu Aarthy, Samson Mani, Sridevi Velusami, Shirley Sundarsingh, Thangarajan Rajkumar. Role of Circulating Cell-Free DNA in CancersMolecular Diagnosis & Therapy 2015; 19(6): 339 doi: 10.1007/s40291-015-0167-y
53
Jari Intra, Maria-Elisa Perotti, Giulio Pavesi, David Horner. Comparative and phylogenetic analysis of α-l-fucosidase genesGene 2007; 392(1-2): 34 doi: 10.1016/j.gene.2006.11.002
54
Collin Bachert, Claus Fimmel, Adam D. Linstedt. Endosomal Trafficking and Proprotein Convertase Cleavage of cis Golgi Protein GP73 Produces Marker for Hepatocellular CarcinomaTraffic 2007; 8(10): 1415 doi: 10.1111/j.1600-0854.2007.00621.x
55
Gabriele Catyana Krause, Kelly Goulart Lima, Gabriela Viegas Haute, Aline Daniele Schuster, Henrique Bregolin Dias, Fernanda Cristina Mesquita, Leonardo Pedrazza, Elisa Simon Marczak, Bruno Souza Basso, Anderson Catarina Velasque, Bianca Andrade Martha, Fernanda Bordignon Nunes, Márcio Vinícius Fagundes Donadio, Jarbas Rodrigues de Oliveira. Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cellsBiomedicine & Pharmacotherapy 2017; 89: 358 doi: 10.1016/j.biopha.2017.01.178
56
Ying Sun, Xiaoyuan Zheng, Hui Yuan, Geng Chen, Jiahe Ouyang, Jingfeng Liu, Xiaolong Liu, Xiaohua Xing, Bixing Zhao. Proteomic analyses reveal divergent ubiquitylation patterns in hepatocellula carcinoma cell lines with different metastasis potentialJournal of Proteomics 2020; 225: 103834 doi: 10.1016/j.jprot.2020.103834
57
Michael J. Reiter, Justin E. Costello, Ryan B. Schwope, Christopher J. Lisanti, Michael B. Osswald. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image InterpretationJournal of Computer Assisted Tomography 2015; 39(6): 825 doi: 10.1097/RCT.0000000000000297
58
Hao Zhang, Xuebing Chen, Jian Zhang, Xianwei Wang, Huijuan Chen, Lin Liu, Shanling Liu. Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review)International Journal of Oncology 2019;  doi: 10.3892/ijo.2019.4909
59
Yoshinori INAGAKI, Huan Li XU, Kiyoshi HASEGAWA, Taku AOKI, Yoshifumi BECK, Yasuhiko SUGAWARA, Wei TANG, Norihiro KOKUDO. Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosisJournal of Digestive Diseases 2011; 12(6): 481 doi: 10.1111/j.1751-2980.2011.00521.x
60
Franck Chiappini. Circulating Tumor Cells Measurements in Hepatocellular CarcinomaInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/684802
61
Ya-Wen Chen, Huay-Ben Pan, Hui-Hwa Tseng, Yu-Ting Hung, Jer-Shyung Huang, Chen-Pin Chou. Assessment of Blood Flow in Hepatocellular Carcinoma: Correlations of Computed Tomography Perfusion Imaging and Circulating Angiogenic FactorsInternational Journal of Molecular Sciences 2013; 14(9): 17536 doi: 10.3390/ijms140917536
62
Yan Zhou, Beili Wang, Jiong Wu, Chunyan Zhang, Yiwen Zhou, XinRong Yang, Jian Zhou, Wei Guo, Jia Fan. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resectionBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2526-4
63
Ibtisam M. Farid, Iman M. Hamza, Dina M. El-Abd, Abeer M. Mohyi, Mona M.A. AbdulLatif, Adel T. Aref, Dina M. Hamza. Transforming growth factor-β1 gene expression in hepatocellular carcinoma: A preliminary reportArab Journal of Gastroenterology 2014; 15(3-4): 142 doi: 10.1016/j.ajg.2014.10.007
64
Johannes C. Melms, Rohit Thummalapalli, Kristin Shaw, Huihui Ye, Leo Tsai, Rupal S. Bhatt, Benjamin Izar. Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimicJournal for ImmunoTherapy of Cancer 2018; 6(1) doi: 10.1186/s40425-018-0394-y
65
Amal Saad-Hussein, Safia Beshir, Mona M. Taha, Eman M. Shahy, Weam Shaheen, Ebtesam A. Abdel-Shafy, Eman Thabet. Early prediction of liver carcinogenicity due to occupational exposure to pesticidesMutation Research/Genetic Toxicology and Environmental Mutagenesis 2019; 838: 46 doi: 10.1016/j.mrgentox.2018.12.004
66
Tim Nagel, Florentine Klaus, Ines Gil Ibanez, Henning Wege, Ansgar Lohse, Bernd Meyer. Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma—correlation with liver cancer and liver cirrhosisAnalytical and Bioanalytical Chemistry 2018; 410(30): 7965 doi: 10.1007/s00216-018-1418-7
67
Wei Li, Philip T Cagle, Rafael C Botero, John J Liang, Zhaoping Zhang, Dongfeng Tan. Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research 2008; 27(1) doi: 10.1186/1756-9966-27-2
68
Ahmed M. Tahon, Magdy Z. El-Ghanam, Samy Zaky, Tarek Mostafa Emran, Ali M. Bersy, Fathiya El-Raey, Elsayed A.Z., Amr M. El Kharsawy, Dina Johar. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic PatientsJournal of Gastrointestinal Cancer 2019; 50(3): 434 doi: 10.1007/s12029-018-0095-2
69
Mohammad Heiat, Masoud Negahdary. Sensitive diagnosis of alpha-fetoprotein by a label free nanoaptasensor designed by modified Au electrode with spindle-shaped gold nanostructureMicrochemical Journal 2019; 148: 456 doi: 10.1016/j.microc.2019.05.004
70
Roberta W. C. Pang, Jae Won Joh, Philip J. Johnson, Morito Monden, Timothy M. Pawlik, Ronnie T. P. Poon. Biology of Hepatocellular CarcinomaAnnals of Surgical Oncology 2008; 15(4): 962 doi: 10.1245/s10434-007-9730-z
71
Yuling Gan, Qiuzhen Liang, Xinghua Song. Diagnostic value of alpha-l-fucosidase for hepatocellular carcinoma: a meta-analysisTumor Biology 2014; 35(5): 3953 doi: 10.1007/s13277-013-1563-8
72
Shilu Mathew, Ashraf Ali, Hany Abdel-Hafiz, Kaneez Fatima, Mohd Suhail, Govindaraju Archunan, Nargis Begum, Syed Jahangir, Muhammad Ilyas, Adeel G.A. Chaudhary, Mohammad Al Qahtani, Salem Mohamad Bazarah, Ishtiaq Qadri. Biomarkers for virus-induced hepatocellular carcinoma (HCC)Infection, Genetics and Evolution 2014; 26: 327 doi: 10.1016/j.meegid.2014.06.014
73
Ivonne Nel, Hideo A Baba, Frank Weber, Barbara Sitek, Martin Eisenacher, Helmut E Meyer, Joerg F Schlaak, Andreas-Claudius Hoffmann. IGFBP1in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinomaBiomarkers in Medicine 2014; 8(5): 687 doi: 10.2217/bmm.14.23
74
Asmaa I Gomaa, Shahid A Khan, Edward LS Leen, Imam Waked, Simon D Taylor-Robinson. Diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology 2009; 15(11): 1301-1314 doi: 10.3748/wjg.15.1301
75
Nahla M. Shalably, Rehab Badawi, Nehad Hawash, Sherief Abd-Elsalam, Walaa Elkhalawany, Amal Abd EI Hameed, Galal El-Din Alkassas. Evaluation of Fucosylated Haptoglobin as a Diagnostic Biomarker for Hepatocellular Carcinoma in EgyptThe Open Biomarkers Journal 2019; 9(1): 31 doi: 10.2174/1875318301909010031
76
Eric Waidely, Abdul-Rahman Obaid Al-Yuobi, A. S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Serum protein biomarkers relevant to hepatocellular carcinoma and their detectionThe Analyst 2016; 141(1): 36 doi: 10.1039/C5AN01884F
77
Beenish Rahat, Manjula Kiran, Roli Saxena, Yogesh K Chawla, Rati R Sharma, Jyotdeep Kaur. Microsomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian PopulationJournal of Clinical and Experimental Hepatology 2012; 2(2): 104 doi: 10.1016/S0973-6883(12)60097-8
78
Toshiro Masuda, Toru Beppu, Kei Horino, Hiroyuki Komori, Hiromitsu Hayashi, Hirohisa Okabe, Ryu Otao, Hasita Horlad, Takatoshi Ishiko, Hiroshi Takamori, Ken Kikuchi, Hideo Baba. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinomaJournal of Surgical Oncology 2010; 102(5): 490 doi: 10.1002/jso.21451
79
Shelli M. Morris, Ji Yeon Baek, Amanda Koszarek, Samornmas Kanngurn, Sue E. Knoblaugh, William M. Grady. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 lossHepatology 2012; 55(1): 121 doi: 10.1002/hep.24653
80
Mohammed A. Eldesouky, Molham A. Elbakary, Osama E. Shalaby, Mohamed M. Shareef. Orbital Metastasis From Hepatocellular CarcinomaOphthalmic Plastic & Reconstructive Surgery 2014; 30(4): e78 doi: 10.1097/IOP.0b013e31829f3a57
81
Giuseppe Gazzana, Jürgen Borlak. Mapping of the Serum Proteome of Hepatocellular Carcinoma Induced by Targeted Overexpression of Epidermal Growth Factor to Liver Cells of Transgenic MiceJournal of Proteome Research 2008; 7(3): 928 doi: 10.1021/pr070462c
82
Jeong-Yeop Song, Yun Nah Lee, Young Seok Kim, Sang Gyune Kim, Soo Ji Jin, Jung Mi Park, Gyu Seong Choi, Jun Chul Chung, Min Hee Lee, Youn Hee Cho, Moon Han Choi, Dong Choon Kim, Hyun Jong Choi, Jong Ho Moon, Se Hwan Lee, Seung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumorsNuclear Medicine Communications 2015; 36(4): 319 doi: 10.1097/MNM.0000000000000254
83
Yuan Tian, Hui Zhang. Characterization of disease-associatedN-linked glycoproteinsPROTEOMICS 2013; 13(3-4): 504 doi: 10.1002/pmic.201200333
84
Yun Hee Kang, Na Young Ji, Chung Il Lee, Hee Gu Lee, Jae Wha Kim, Young IL Yeom, Dae Ghon Kim, Seung Kew Yoon, Jong Wan Kim, Pil Je Park, Eun Young Song. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinomaAmino Acids 2011; 40(3): 1003 doi: 10.1007/s00726-010-0729-6
85
Long Zhao, Chao Xie, Danqing Liu, Tong Li, Yu Zhang, Chidan Wan. Early Detection of Hepatocellular Carcinoma in Patients with Hepatocirrhosis by Soluble B7-H3Journal of Gastrointestinal Surgery 2017; 21(5): 807 doi: 10.1007/s11605-017-3386-1
86
Binghua Li, Wendu Feng, Ouyang Luo, Tiancheng Xu, Yajuan Cao, Hongyan Wu, Decai Yu, Yitao Ding. Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular CarcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04811-5
87
Mallikarjun Patil, Keyur A. Sheth, Channagiri K. Adarsh. Elevated Alpha Fetoprotein, No Hepatocellular CarcinomaJournal of Clinical and Experimental Hepatology 2013; 3(2): 162 doi: 10.1016/j.jceh.2013.02.246
88
Aducio L. Thiesen. Liver Cancer2021; : 39 doi: 10.36255/exonpublications.livercancer.2021.ch2
89
Mary Levy, Anand Trivedi, Jun Zhang, Lili Miles, Aras N. Mattis, Grace E. Kim, Charles Lassman, Robert A. Anders, Joseph Misdraji, Lisa M. Yerian, Haodong Xu, Deepti Dhall, Hanlin L. Wang. Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liverHuman Pathology 2012; 43(5): 695 doi: 10.1016/j.humpath.2011.06.016
90
JuanPing Yu, Qiang Ma, Bin Zhang, RuiJuan Ma, XiGuang Xu, MingSong Li, WeiWen Xu, Ming Li. Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosisScience China Life Sciences 2013; 56(3): 234 doi: 10.1007/s11427-013-4451-y
91
Mingming Xiao, Yajing Chen, Huan Yu, Su Wei, Kang Yu, Huan Zhao, Ruibing Chen. Analysis of the whole serum proteome using an integrated 2D LC-MS/MS systemAnal. Methods 2014; 6(18): 7157 doi: 10.1039/C4AY01274G
92
Wei Yin Lim, Boon Tong Goh, Sook Mei Khor. Microfluidic paper-based analytical devices for potential use in quantitative and direct detection of disease biomarkers in clinical analysisJournal of Chromatography B 2017; 1060: 424 doi: 10.1016/j.jchromb.2017.06.040
93
Vivek K. Chaturvedi, Anshuman Singh, Sushil K. Dubey, Helal F. Hetta, James John, M.P. Singh. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinomaMicrobial Pathogenesis 2019; 128: 184 doi: 10.1016/j.micpath.2019.01.004
94
Won-Hyeong Park, Ju-Hyun Shim, Seung-Bong Han, Hyung-Jin Won, Yong-Moon Shin, Kang-Mo Kim, Young-Suk Lim, Han-Chu Lee. Clinical Utility of Des-γ-Carboxy Prothrombin Kinetics as a Complement to Radiologic Response in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationJournal of Vascular and Interventional Radiology 2012; 23(7): 927 doi: 10.1016/j.jvir.2012.04.021
95
Noboru Mitsuhashi, Souichi Kobayashi, Tomoko Doki, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Satoshi Nozawa, Katsunori Furukawa, Dan Takeuchi, Kosuke Suda, Seiki Miura, Masaru Miyazaki. Clinical significance of -fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2008; 23(7pt2): e189 doi: 10.1111/j.1440-1746.2008.05340.x
96
Hoang Van Tong, Pham Van Dung, Nguyen Thi Mong Diep, Nguyen Linh Toan. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach [Working Title]2021;  doi: 10.5772/intechopen.98483
97
Tudor Mocan, André L. Simão, Rui E. Castro, Cecília M. P. Rodrigues, Artur Słomka, Bingduo Wang, Christian Strassburg, Aliona Wöhler, Arnulf G. Willms, Miroslaw Kornek. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?Journal of Clinical Medicine 2020; 9(5): 1541 doi: 10.3390/jcm9051541
98
Tarek D. Hussein. Serological tumor markers of hepatocellular carcinoma: a meta-analysisThe International Journal of Biological Markers 2015; 30(1): 32 doi: 10.5301/jbm.5000119
99
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrenceCritical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
100
Hadeer A Aglan, Hanaa H Ahmed, Sayed A El-Toumy, Nadia S Mahmoud. Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action fromin vivostudyTumor Biology 2017; 39(6): 101042831769912 doi: 10.1177/1010428317699127
101
Qianyun Zhang, Xu Wang, Zhenjia Li, Jin-Ming Lin. Evaluation of α-fetoprotein (AFP) in human serum by chemiluminescence enzyme immunoassay with magnetic particles and coated tubes as solid phasesAnalytica Chimica Acta 2009; 631(2): 212 doi: 10.1016/j.aca.2008.10.042
102
Masataka Kashima, Koichiro Yamakado, Haruyuki Takaki, Toshio Kaminou, Noboru Tanigawa, Atsuhiro Nakatsuka, Kan Takeda. Radiofrequency Ablation for the Treatment of Bone Metastases From Hepatocellular CarcinomaAmerican Journal of Roentgenology 2010; 194(2): 536 doi: 10.2214/AJR.09.2975
103
Hua Yang, Fuxia Xiong, Ruizhao Qi, Zhenwen Liu, Ming Lin, Jingan Rui, Jing Su, Rouli Zhou. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinomaJournal of Surgical Oncology 2010; 101(5): 363 doi: 10.1002/jso.21489
104
Gary L. Davis, Jane Dempster, James D. Meler, Douglas W. Orr, Mark W. Walberg, Brian Brown, Brian D. Berger, John K. O'Connor, Robert M. Goldstein. Hepatocellular Carcinoma: Management of an Increasingly Common ProblemBaylor University Medical Center Proceedings 2008; 21(3): 266 doi: 10.1080/08998280.2008.11928410
105
Qi Peng, Gao Chunfang, Fang Meng, Ji Qiang, Zhao Yunpeng, Liu Yan, Sun Xiaojuan. Establishment of a real-time PCR for quantifying transforming growth factor beta1 in blood of hepatocellular carcinoma patientsJournal of Medical Colleges of PLA 2008; 23(4): 228 doi: 10.1016/S1000-1948(08)60047-7
106
Tara Behne, M. Sitki Copur. Biomarkers for Hepatocellular CarcinomaInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/859076
107
JING ZHU, FENG JIANG, HONG-BING NI, MING-BING XIAO, BU-YOU CHEN, WEN-KAI NI, CUI-HUA LU, RUN-ZHOU NI. Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinomaExperimental and Therapeutic Medicine 2013; 5(1): 89 doi: 10.3892/etm.2012.783
108
Fei Fan, Haiying Shen, Guojun Zhang, Xingyu Jiang, Xixiong Kang. Chemiluminescence immunoassay based on microfluidic chips for α-fetoproteinClinica Chimica Acta 2014; 431: 113 doi: 10.1016/j.cca.2014.02.003
109
Hong Zhang, Feng Li, Qun Wei, Yu-Fei Zhu. Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascitesMedical Oncology 2011; 28(S1): 670 doi: 10.1007/s12032-010-9731-9
110
Edmund Kwok-Kwan Tung, Carmen Ka-Man Mak, Sarwat Fatima, Regina Cheuk-Lam Lo, Heng Zhao, Chunsheng Zhang, Hongyue Dai, Ronnie Tung-Ping Poon, Man-Fung Yuen, Ching-Lung Lai, Jin-jun Li, John Moon-Ching Luk, Irene Oi-Lin Ng. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinomaLiver International 2011; 31(10): 1494 doi: 10.1111/j.1478-3231.2011.02597.x
111
Hao Huang, Xue-Ping Wang, Xiao-Hui Li, Hao Chen, Xin Zheng, Jian-Hua Lin, Ting Kang, Lin Zhang, Pei-Song Chen. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinomaBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3523-y
112
Xinxin Li, Haitao Yu, Xiaohua Gan, Xiaoyuan Xia, Pengcheng Xu, Jungang Li, Min Liu, Yongxiang Li. Integrated MEMS/NEMS Resonant Cantilevers for Ultrasensitive Biological DetectionJournal of Sensors 2009; 2009: 1 doi: 10.1155/2009/637874
113
Eric C. Han, Ying-Shiung Lee, Wen-Sin Liao, Yu-Ching Liu, Hsin-Yi Liao, Long-Bin Jeng. Direct tissue analysis by MALDI-TOF mass spectrometry in human hepatocellular carcinomaClinica Chimica Acta 2011; 412(3-4): 230 doi: 10.1016/j.cca.2010.09.021
114
Hyejung Cha, Eun Jung Lee, Jinsil Seong. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapyWorld Journal of Gastroenterology 2017; 23(11): 2077-2085 doi: 10.3748/wjg.v23.i11.2077
115
Péter Tátrai, Áron Somorácz, Enkhjargal Batmunkh, Peter Schirmacher, András Kiss, Zsuzsa Schaff, Péter Nagy, Ilona Kovalszky. Agrin and CD34 Immunohistochemistry for the Discrimination of Benign Versus Malignant Hepatocellular LesionsAmerican Journal of Surgical Pathology 2009; 33(6): 874 doi: 10.1097/PAS.0b013e318194b3ea
116
Sejong Chun, Su Yeon Rhie, Chang-Seok Ki, Jee Eun Kim, Hyung-Doo Park. Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areasAnnals of Hepatology 2015; 14(6): 881 doi: 10.5604/16652681.1171776
117
Yaofang Hu, Peng Zuo, Bang-Ce Ye. Label-free electrochemical impedance spectroscopy biosensor for direct detection of cancer cells based on the interaction between carbohydrate and lectinBiosensors and Bioelectronics 2013; 43: 79 doi: 10.1016/j.bios.2012.11.028
118
J.-L. Payen, M.-A. Robic. Conduite à tenir devant une élévation des gamma-glutamyl-transférasesEMC - Hépatologie 2007; 2(4): 1 doi: 10.1016/S1155-1976(07)46233-7
119
Seo Young Park, Jiyou Han, Jong Bin Kim, Man-Gil Yang, Yoon Jun Kim, Hee-Joung Lim, Su Yeon An, Jong-Hoon Kim. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinomaEuropean Journal of Cancer 2014; 50(2): 341 doi: 10.1016/j.ejca.2013.09.021
120
Yi-Jun Zhang, Jie-Wei Chen, Xiao-Sheng He, Hui-Zhong Zhang, Yi-Hong Ling, Jia-Huai Wen, Wei-Hao Deng, Peng Li, Jing-Ping Yun, Dan Xie, Mu-Yan Cai. SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic AdenocarcinomasEBioMedicine 2018; 28: 62 doi: 10.1016/j.ebiom.2018.01.001
121
Matthew R. Pincus, Philip M. Tierno, Maly Fenelus, Wilbur B. Bowne, Martin H. Bluth. Henry's Clinical Diagnosis and Management by Laboratory Methods2011; : 296 doi: 10.1016/B978-1-4377-0974-2.00021-X
122
Zhenyu Zhang, Jinfeng Zhu, Yansong Huang, Weibing Li, Hongqiu Cheng. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathwayDiagnostic Pathology 2018; 13(1) doi: 10.1186/s13000-018-0763-3
123
Hanaa H. Ahmed, Wafaa Gh. Shousha, Aziza B. Shalby, Hatem A. El-Mezayen, Nora N. Ismaiel, Nadia S. Mahmoud. Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat modelTumor Biology 2015; 36(3): 1667 doi: 10.1007/s13277-014-2767-2
124
Ka Yin Lui, Hao-ran Peng, Jin-rong Lin, Chun-hui Qiu, Hu-an Chen, Rong-dang Fu, Chang-jie Cai, Min-qiang Lu. Pseudogene integrator complex subunit 6 pseudogene 1 (INTS6P1) as a novel plasma-based biomarker for hepatocellular carcinoma screeningTumor Biology 2016; 37(1): 1253 doi: 10.1007/s13277-015-3899-8
125
Hammad Zafar, Mamoon Ur Rashid, Deepika Sarvepalli, Muzammil Muhammad Khan, Bayarmaa Mandzhieva, Akriti Gupta Jain, Rima Shobar, Anum Jalil, Sarfraz Ahmad. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers2020; : 287 doi: 10.1007/978-3-030-48405-7_13
126
S M Morris, K T Carter, J Y Baek, A Koszarek, M M Yeh, S E Knoblaugh, W M Grady. TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivationOncogene 2015; 34(25): 3273 doi: 10.1038/onc.2014.258
127
Meng Qiao, Arthur B. Pardee. Biomarkers, regerons, and pathways to lethal cancerJournal of Cellular Biochemistry 2007; 102(5): 1076 doi: 10.1002/jcb.21534
128
Giovanni Centini, Lucia Rosignoli, Elisa Faldini, Francesco Calonaci, Felice Petraglia. Medicina dell’età prenatale2008; : 209 doi: 10.1007/978-88-470-0688-1_12
129
YAN-JIE ZHAO, QIANG JU, GUAN-CHENG LI. Tumor markers for hepatocellular carcinomaMolecular and Clinical Oncology 2013; 1(4): 593 doi: 10.3892/mco.2013.119
130
Rehab A. Mohamed, Hend M. Maghraby, Eman M. Abd El Salam, Hala M. Nageb, Eman E. Ahmad, Nagwa A. Mohamed. Evaluation of serum endoglin as noninvasive marker in hepatocellular carcinomaThe Egyptian Journal of Internal Medicine 2015; 27(1): 15 doi: 10.4103/1110-7782.155832
131
Shun-Jun Fu, Chao-Ying Qi, Wei-Kai Xiao, Shao-Qiang Li, Bao-Gang Peng, Li-Jian Liang. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resectionSurgery 2013; 154(3): 536 doi: 10.1016/j.surg.2013.02.014
132
Abdel-Rahman N Zekri, Abeer A Bahnassy, Sabrin A Abdel-Wahab, Medhat M Khafagy, Samah A Loutfy, Hessam Radwan, Sabry M Shaarawy. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4Journal of Gastroenterology and Hepatology 2009; 24(3): 416 doi: 10.1111/j.1440-1746.2008.05699.x
133
Hanaa H. Ahmed, Hanaa M. Rady, Soheir E. Kotob. Evidences for the antitumor potentiality of Hemimycale arabica and Negombata magnifica mesohyls in hepatocellular carcinoma rat modelMedicinal Chemistry Research 2018; 27(5): 1538 doi: 10.1007/s00044-018-2171-3
134
Wei Wu, Dengfu Yao, Liwei Qiu, Xiaoxiao Gu, Xinhua Wu. Quantitative analysis of hepatoma-specific α-fetoprotein (HS-AFP) by a new mini-column affinity chromatography and its clinical value in diagnosis of hepatocellular carcinomaThe Chinese-German Journal of Clinical Oncology 2008; 7(3): 131 doi: 10.1007/s10330-007-0167-4
135
Andreea Cioca, Anca Cimpean, Raluca Ceausu, Ana-Maria Fit, Teodor Zaharie, Nadim Al-Hajjar, Vlad Puia, Marius Raica. Crosstalk between EGFR and p53 in Hepatocellular CarcinomaAsian Pacific Journal of Cancer Prevention 2014; 15(19): 8069 doi: 10.7314/APJCP.2014.15.19.8069
136
Han Chong Toh, Pei-Jer Chen, Brian I. Carr, Jennifer J. Knox, Sharlene Gill, Peter Ansell, Evelyn M. McKeegan, Barry Dowell, Michelle Pedersen, Qin Qin, Jiang Qian, Frank A. Scappaticci, Justin L. Ricker, Dawn M. Carlson, Wei Peng Yong. Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinomaCancer 2013; 119(2): 380 doi: 10.1002/cncr.27758
137
ZHIKUN LIU, QI LING, JIANGUO WANG, HAIYANG XIE, XIAO XU, SHUSEN ZHENG. Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosisOncology Letters 2013; 6(1): 125 doi: 10.3892/ol.2013.1337
138
Xiao-Fei Liu, Zhi-De Hu, Xiao-Cui Liu, Yuan Cao, Chun-Mei Ding, Cheng-Jin Hu. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: A systematic review and meta-analysisClinical Biochemistry 2014; 47(3): 196 doi: 10.1016/j.clinbiochem.2013.12.007
139
Yamini Sabherwal, Vicki L. Rothman, Ronnie T.P. Poon, George P. Tuszynski. Clinical significance of serum angiocidin levels in hepatocellular carcinomaCancer Letters 2007; 251(1): 28 doi: 10.1016/j.canlet.2006.10.023
140
Swarupa Ghosh, Sandhya Rekha Dungdung, Somsubhra Thakur Choudhury, Somsuta Chakraborty, Nirmalendu Das. Mitochondria protection with ginkgolide B-loaded polymeric nanocapsules prevents diethylnitrosamine-induced hepatocarcinoma in ratsNanomedicine 2014; 9(3): 441 doi: 10.2217/nnm.13.56
141
Nuerbieke Pulati, Zegao Zhang, Aireti Gulimilamu, Xiaoli Qi, Jie Yang. HPV16+‐miRNAs in cervical cancer and the anti‐tumor role played by miR‐5701The Journal of Gene Medicine 2019; 21(11) doi: 10.1002/jgm.3126
142
Eray Yagmur, Mohamed Rizk, Sven Stanzel, Claus Hellerbrand, Frank Lammert, Christian Trautwein, Hermann E. Wasmuth, Axel M. Gressner. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinomaEuropean Journal of Gastroenterology & Hepatology 2007; 19(9): 755 doi: 10.1097/MEG.0b013e3282202bea
143
Xue-En Liu, Liesbeth Desmyter, Chun-Fang Gao, Wouter Laroy, Sylviane Dewaele, Valerie Vanhooren, Ling Wang, Hui Zhuang, Nico Callewaert, Claude Libert, Roland Contreras, Cuiying Chen. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virusHepatology 2007; 46(5): 1426 doi: 10.1002/hep.21855
144
Yanli He, Haijun Lu, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part AProgress in Molecular Biology and Translational Science 2019; 162: 199 doi: 10.1016/bs.pmbts.2019.01.001
145
Zhixiang Zhang, Hanhan Bao, Haitao Yu, Xinxin Li. ng/ml-Level Alpha-Fetoprotein Immuno-Detection with Torsion-Mode Cantilever Sensors for Early-Stage Heptocellular Carcinoma DiagnosisTRANSDUCERS 2007 - 2007 International Solid-State Sensors, Actuators and Microsystems Conference 2007; : 1785 doi: 10.1109/SENSOR.2007.4300500
146
Ning Gan, Ling Hua Meng, Feng Wang. Amperometric immunosensor for α-fetoprotein antigen in human serum based on co-immobilizing dinuclear copper complex and gold nanoparticle doped chitosan filmJournal of Physics: Conference Series 2009; 188: 012047 doi: 10.1088/1742-6596/188/1/012047
147
Ke ZOU, Jihang JU, Hong XIE. Novel Tumor-associated Antigen of Hepatocellular Carcinoma Defined by Monoclonal Antibody E4-65Acta Biochimica et Biophysica Sinica 2007; 39(5): 359 doi: 10.1111/j.1745-7270.2007.00288.x
148
Jose A. Nuevo-Gonzalez, Juan C. Cano-Ballesteros, Beatriz Lopez, Juan A. Andueza-Lillo, Luis Audibert. Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a CaseJournal of Gastrointestinal Cancer 2012; 43(S1): 28 doi: 10.1007/s12029-011-9310-0
149
Fayza A. Rahamtalla, Mohammed S. M. Abdalla, Salma B. M. Mudawi, Mohammed A. H. Kheir Elsid, Iman M. Shammat. Estimation of telomerase, AFP, and AFP-L3 levels in Sudanese patients with hepatocellular carcinoma and chronic liver diseasesComparative Clinical Pathology 2018; 27(5): 1133 doi: 10.1007/s00580-018-2709-2
150
Roli Saxena, Yogesh Kumar Chawla, Indu Verma, Jyotdeep Kaur. Interleukin-1 Polymorphism and Expression in Hepatitis B Virus-Mediated Disease Outcome in IndiaJournal of Interferon & Cytokine Research 2013; 33(2): 80 doi: 10.1089/jir.2012.0093
151
HIROKI NISHIKAWA, AKIRA ARIMOTO, TOMOKO WAKASA, RYUICHI KITA, TORU KIMURA, YUKIO OSAKI. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinomaInternational Journal of Oncology 2013; 42(1): 151 doi: 10.3892/ijo.2012.1711
152
Ahmet Gurakar, Michelle Ma, Jacqueline Garonzik-Wang, Amy Kim, Robert A. Anders, Kiyoko Oshima, Christos Georgiades, Merve Gurakar, Shane Ottmann, Andrew M. Cameron, Benjamin Philosophe, Behnam Saberi. Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular CarcinomasAnnals of Hepatology 2018; 17(6): 1052 doi: 10.5604/01.3001.0012.7206
153
Xu Yu, He-Shun Xia, Zuo-Dong Sun, Yi Lin, Kun Wang, Jing Yu, Hao Tang, Dai-Wen Pang, Zhi-Ling Zhang. On-chip dual detection of cancer biomarkers directly in serum based on self-assembled magnetic bead patterns and quantum dotsBiosensors and Bioelectronics 2013; 41: 129 doi: 10.1016/j.bios.2012.08.007
154
Umberto Cillo, Tommaso Giuliani, Marina Polacco, Luz Maria Herrero Manley, Gino Crivellari, Alessandro Vitale. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationWorld Journal of Gastroenterology 2016; 22(1): 232-252 doi: 10.3748/wjg.v22.i1.232
155
Fu-Tao Zhao, Zhan-Sheng Jia, Qun Yang, Le Song, Xiao-Jing Jiang. S100A14 Promotes the Growth and Metastasis of Hepatocellular CarcinomaAsian Pacific Journal of Cancer Prevention 2013; 14(6): 3831 doi: 10.7314/APJCP.2013.14.6.3831
156
Nabil M. Abdel-Hamid, Amer Hasan Abdullah. Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinomaClinical and Experimental Medicine 2019; 19(1): 115 doi: 10.1007/s10238-018-0537-y
157
Michela Di Michele, Simone Marcone, Lucia Cicchillitti, Anna Della Corte, Cristiano Ferlini, Giovanni Scambia, Maria Benedetta Donati, Domenico Rotilio. Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkersJournal of Proteomics 2010; 73(5): 879 doi: 10.1016/j.jprot.2009.11.012
158
Natasa Pavlovic, Bhavna Rani, Pär Gerwins, Femke Heindryckx. Platelets as Key Factors in Hepatocellular CarcinomaCancers 2019; 11(7): 1022 doi: 10.3390/cancers11071022
159
Issei Saeki, Takahiro Yamasaki, Norikazu Tanabe, Takuya Iwamoto, Toshihiko Matsumoto, Yohei Urata, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Naoki Yamamoto, Koichi Uchida, Shuji Terai, Isao Sakaida, Seung Up Kim. A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion ChemotherapyPLOS ONE 2015; 10(5): e0126649 doi: 10.1371/journal.pone.0126649
160
Jaromír Kotyza. Interleukin-8 (CXCL8) in Tumor Associated Non-Vascular Extracellular Fluids: Its Diagnostic and Prognostic Values. A ReviewThe International Journal of Biological Markers 2012; 27(3): 169 doi: 10.5301/JBM.2012.9261
161
Haiyan Lu, Hua Zhang, Yipo Xiao, Konstantin Chingin, Chao Dai, Feng Wei, Nanya Wang, Vladimir Frankevich, Vitaly Chagovets, Fan Zhou, Huanwen Chen. Comparative study of alterations in phospholipid profiles upon liver cancer in humans and miceThe Analyst 2020; 145(20): 6470 doi: 10.1039/D0AN01080D
162
Stefan Heringlake, Michael Hofdmann, Anette Fiebeler, Michael P. Manns, Wolff Schmiegel, Andrea Tannapfel. Identification and expression analysis of the aldo–ketoreductase1-B10 gene in primary malignant liver tumoursJournal of Hepatology 2010; 52(2): 220 doi: 10.1016/j.jhep.2009.11.005
163
Atsushi Nanashima, Syuuichi Tobinaga, Masaki Kunizaki, Satoshi Miuma, Naota Taura, Hiroaki Takeshita, Shigekazu Hidaka, Terumitsu Sawai, Kazuhiko Nakao, Takeshi Nagayasu. Strategy of treatment for hepatocellular Carcinomas with vascular infiltration in patients undergoing hepatectomyJournal of Surgical Oncology 2010; 101(7): 557 doi: 10.1002/jso.21534
164
Hana Park, Jun Yong Park. Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular CarcinomaBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/310427
165
Neven A. Hagag, Yasser B. M. Ali, Ahmed A. Elsharawy, Roba M. Talaat. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 ExpressionJournal of Gastrointestinal Cancer 2020; 51(1): 234 doi: 10.1007/s12029-019-00234-9
166
Priyal Chikhaliwala, Sudeshna Chandra. Poly‐amidoamine Dendrimers@Fe3O4Based Electrochemiluminescent Nanomaterials for Biosensing of Liver Cancer BiomarkersElectroanalysis 2020; 32(11): 2404 doi: 10.1002/elan.202060075
167
Christoph Roderburg, Jhenee Bubenzer, Michael Spannbauer, Nicole do O, Andreas Mahnken, Tom Ludde, Christian Trautwein, Jens J Tischendorf. Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenibWorld Journal of Hepatology 2010; 2(6): 239-242 doi: 10.4254/wjh.v2.i6.239
168
Mohamed S. Othman, Ahmed M. Aref, Amal A. Mohamed, Wesam A. Ibrahim. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian PatientsISRN Hepatology 2013; 2013: 1 doi: 10.1155/2013/412317
169
Yousri M. Hussein, Fouad E. Morad, Magda A. Gameel, Wafaa A. Emam, Wael H. El Sawy, Shereen A. El Tarhouny, Eman S. Bayomy, Nermin Raafat. MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patientsMedical Oncology 2012; 29(5): 3055 doi: 10.1007/s12032-012-0257-1
170
Xiaoting Li, Beibei Chen, Man He, Guangyang Xiao, Bin Hu. Gold nanoparticle labeling with tyramide signal amplification for highly sensitive detection of alpha fetoprotein in human serum by ICP-MSTalanta 2018; 176: 40 doi: 10.1016/j.talanta.2017.08.007
171
Anastasia Asimakopoulou, Mihael Vucur, Tom Luedde, Silvia Schneiders, Stavroula Kalampoka, Thomas Weiss, Ralf Weiskirchen. Perilipin 5 and Lipocalin 2 Expression in Hepatocellular CarcinomaCancers 2019; 11(3): 385 doi: 10.3390/cancers11030385
172
Zheng Guo, Jing Wang, Li Li, Rong Liu, Jin Fang, Bin Tie. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolizationWorld Journal of Clinical Cases 2020; 8(16): 3493-3502 doi: 10.12998/wjcc.v8.i16.3493
173
Ahmed A. Raouf, Eman A. Gaweesh, Hanaa M. Badran, Manal O. El-Hamshary, Mohamed Shereef A. Hamed. Molecular diagnosis of hepatocellular carcinomaEgyptian Liver Journal 2014; 4(1): 20 doi: 10.1097/01.ELX.0000440959.92481.b1
174
Hanan H. Soliman, Hala Nagy, Nesreen Kotb, Mohamed A. Alm El-Din. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinomaThe International Journal of Biological Markers 2012; 27(2): 125 doi: 10.5301/JBM.2012.9097
175
Qing-Qin Hao, Guang-Yi Chen, Jun-Hua Zhang, Jia-He Sheng, Yun Gao. Diagnostic value of long noncoding RNAs for hepatocellular carcinomaMedicine 2017; 96(28): e7496 doi: 10.1097/MD.0000000000007496
176
Gurjot Singh, Eric M Yoshida, Sahaj Rathi, Vladimir Marquez, Peter Kim, Siegfried R Erb, Baljinder S Salh. Biomarkers for hepatocellular cancerWorld Journal of Hepatology 2020; 12(9): 558-573 doi: 10.4254/wjh.v12.i9.558
177
XIAOBO JIA, YINGTANG GAO, DAOKUAN ZHAI, JIAO LIU, YAJIE WANG, LI JING, ZHI DU. Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinomaOncology Letters 2015; 9(5): 2347 doi: 10.3892/ol.2015.3050
178
Zeting Huang, Bin Zhou, Zheng Li, Cantong Liu, Chunwen Zheng, Ruijie Zeng, Chaoqun Hong, Liyan Xu, Enmin Li, Yuhui Peng, Yiwei Xu. Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinomaCancer Biomarkers 2020; 29(1): 139 doi: 10.3233/CBM-201687
179
Joon Seon Yang, Juan Qiao, Jin Yong Kim, Liping Zhao, Li Qi, Myeong Hee Moon. Online Proteolysis and Glycopeptide Enrichment with Thermoresponsive Porous Polymer Membrane Reactors for Nanoflow Liquid Chromatography-Tandem Mass SpectrometryAnalytical Chemistry 2018; 90(5): 3124 doi: 10.1021/acs.analchem.7b04273
180
Janio Szklaruk, Eddie K. Abdalla, Ahmed O. Kaseb, Sunil Krishnan. Oncologic Imaging: A Multidisciplinary Approach2012; : 95 doi: 10.1016/B978-1-4377-2232-1.00009-7
181
Manjula Kiran, Yogesh Kumar Chawla, Jyotdeep Kaur. Glutathione-S-Transferase and Microsomal Epoxide Hydrolase Polymorphism and Viral-Related Hepatocellular Carcinoma Risk in IndiaDNA and Cell Biology 2008; 27(12): 687 doi: 10.1089/dna.2008.0805
182
Petra Thulin, Gunnar Nordahl, Marcus Gry, Getnet Yimer, Eleni Aklillu, Eyasu Makonnen, Getachew Aderaye, Lars Lindquist, C. Mikael Mattsson, Björn Ekblom, Daniel J. Antoine, B. Kevin Park, Stig Linder, Alison H. Harrill, Paul B. Watkins, Björn Glinghammar, Ina Schuppe-Koistinen. Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohortsLiver International 2014; 34(3): 367 doi: 10.1111/liv.12322
183
Christophe Duvoux. Transplantation hépatique pour carcinome hépatocellulaireGastroentérologie Clinique et Biologique 2006; 30(12): 1343 doi: 10.1016/S0399-8320(06)73551-5
184
Ming-Chao Tsai, Jing-Houng Wang, Chao-Hung Hung, Kwong-Ming Kee, Yi-Hao Yen, Chuan-Mo Lee, Tsung-Hui Hu, Chien-Hung Chen, Sheng-Nan Lu. Favorable α-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablationJournal of Gastroenterology and Hepatology 2010; 25(3): 605 doi: 10.1111/j.1440-1746.2009.06115.x
185
Nabil Mohie Abdel-Hamid, M. M. Abouzied, M. H. Nazmy, M. A. Fawzy, A. S. Gerges. A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinomaTumor Biology 2016; 37(2): 2539 doi: 10.1007/s13277-015-4025-7
186
Zhiyong Guo, Lin Wu, Yufang Hu, Sui Wang, Xing Li. Potential-resolved “in-electrode” type electrochemiluminescence immunoassay based on functionalized g-C 3 N 4 nanosheet and Ru-NH 2 for simultaneous determination of dual targetsBiosensors and Bioelectronics 2017; 95: 27 doi: 10.1016/j.bios.2017.03.013
187
Wenling Zhang, Yumei Huang, Jian Xu. Clinical Molecular Diagnostics2021; : 261 doi: 10.1007/978-981-16-1037-0_21
188
Kanjana Thumanu, Suleeporn Sangrajrang, Thiravud Khuhaprema, Anant Kalalak, Waraporn Tanthanuch, Siwatt Pongpiachan, Philip Heraud. Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary studyJournal of Biophotonics 2014; 7(3-4): 222 doi: 10.1002/jbio.201300183